cp wire

CP Wire Articles

MorphoSys Patents Ruled Invalid in Patent Lawsuit Against Janssen and Genmab

MorphoSys AG (FSE: MOR; Prime Standard Segment, MDAX & TecDAX; NASDAQ: MOR) announced on 1/26/19 that it was informed that in its lawsuit against Janssen Biotech and Genmab A/S, the United... read more

Mon, 01/28/19 - 10:10 am
Last week in biopharma-earnings reports, drug pricing, a new GENE CEO and more

Tuesday

This was a short work week for many due to MLK Day on Monday, but Tuesday started off Q4 earnings... read more
Sun, 01/27/19 - 07:07 pm
Coherus BioSciences Announces Settlement with AbbVie to Market its Humira Biosimilar Candidate
  • Coherus’ license period in the U.S. commences on December 15, 2023
  • Coherus will pay royalties to AbbVie
  • The company has six candidates in development

Coherus... read more

Fri, 01/25/19 - 10:41 am
Basilea Enters Collaboration With Roche to Study BAL087 in Combination With Tecentriq in Urothelial Cancer
  • ArQule is eligible to receive up to $326 million in regulatory and commercial milestone payments related to the BAL087 license agreement
  • BAL087 has U.S. and EU orphan drug... read more
Thu, 01/24/19 - 10:38 am
Evotec Receives Milestone Payment for Beginning Phase II NASH Clinical Trial

Evotec AG (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809) announced today that it has earned a $ 2 m milestone payment from Second Genome, Inc., a leading microbiome science-based... read more

Thu, 01/24/19 - 10:12 am

Pages